Pharmaceutical & biotechnology companies dominated the biologics safety testing products market in 2025 with a share of 56.0%. North America accounted for the largest market share, by region, in 2025: ...
New York, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biologics Safety Testing Market Research Report by Test Type, by Application - Global Forecast to 2025 ...
Dublin, April 22, 2026 (GLOBE NEWSWIRE)-- The "Biologics Safety Testing Market by Type of Offering, Type of Testing, Type of Modality, Type of Technology and Geographical Regions - Trends and Forecast ...
Biological Safety Testing Market By Product Type, By Test Type (Endotoxin Tests, Sterility Tests, Cell Line Authentication and Characterization Tests, Bioburden Tests, Adventitious Agent Detection ...
WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its Biosafety Testing Center in Suzhou has successfully passed a Good ...
MilliporeSigma, Merck KGaA’s life science business, opened the second phase of its new €29 million ($31.7 million) Biologics Testing Center in China, adding 1,500 m 2 to the lab opened last year.
The introduction of biologicals into our drug armamentarium is complicating stability testing. For these complex molecules neither physicochemical data nor bioassays alone provide the complete picture ...
DELRAY BEACH, Fla., May 4, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Biologics Safety Testing is projected to grow from about USD 5.57 billion in 2026 to USD 9.66 billion by 2031, at a ...
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34624144 The growth of advanced modalities such as cell & gene therapies and mRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results